A small study suggests lack of benefit, but its methods are flawed.
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder that produces progressive weakness of limb, axial, bulbar, and respiratory muscles, with death typically occurring 3 to 5 years after symptom onset. Noninvasive ventilation (NIV) prolongs survival and improves quality of life. Direct intramuscular electrical stimulation of the diaphragm, or diaphragmatic pacing (DP), has emerged as a potential therapy despite the absence of supportive randomized, controlled trial data. To determine whether DP slows the rate of vital capacity (VC) decline or prolongs ventilator-free survival compared with NIV alone, researchers retrospectively reviewed data from a cohort of 354 patients who did not undergo DP and 8 patients who received DP.
A…
Reviewing Authors
Richard S. Bedlack, MD, PhD
Richard S. Bedlack, MD, PhD
DisclosuresGrant / Research supportNIH NeuroBioBank; ALS Association; NIH/National Institute of Neurological Disorders and Stroke; NIH/National Center for Advancing Translational Sciences; FDA; Department of Defense
Editorial boardsCochrane Collaboration
Leadership positions in professional societiesMuscle Study Group Executive Committee
DisclosuresGrant / Research supportNIH NeuroBioBank; ALS Association; NIH/National Institute of Neurological Disorders and Stroke; NIH/National Center for Advancing Translational Sciences; FDA; Department of Defense
Editorial boardsCochrane Collaboration
Leadership positions in professional societiesMuscle Study Group Executive Committee